3rd Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$3,070,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2008 $3,060,000 Replaced
3rd Quarter - Amendment (this page) Oct 27, 2008 $3,070,000 Yes

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

S. 1547, National Defense Authorization Act for FY 2009 HR. 1585, National Defense Authorization Act for FY 2009 Coverage of Smoking Cessation products under TRICARE S. 1547, Defense Authorization Act of FY 2009 HR. 1585, Defense Authorization Act of FY 2009

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
VERA GRILL —
ANNE WILSON —

Contacted: Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC); Defense, Dept of (DOD)

Bills named: S. 1547 (110th), H.R. 1585 (110th)

Trade (domestic/foreign) TRD

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
STEPHANIE HENNING —
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC)

Bills named: H.R. 4279 (110th)

Taxation/Internal Revenue Code TAX

HR. 2138, R&D tax credit extension 5/07 S. 41, R&D tax credit extension 1/07 S. 41, S. 2209, HR. 1712, R&E tax credit 2007 - all three Tax treaties with Ireland, Bulgaria and Canada H.R. 1424 - Emergency Economic Stabilizaton Act of 2008 H.R. 3997 - Emergency Economic Stabilizaton Act of 2008

LobbyistCovered position, as disclosed
JOSEPH DAMOND —
KIMBERLY JANE PINTER —
ANTHONY PRINCIPI —
ANNE WILSON —

Contacted: Defense, Dept of (DOD); Treasury, Dept of; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; State, Dept of (DOS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP)

Bills named: H.R. 1424 (110th), S. 41 (110th), H.R. 3997 (110th), S. 2209 (110th), H.R. 1712 (110th), H.R. 2138 (110th)

Copyright/Patent/Trademark CPT

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOSEPH DAMOND —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
MYRON KEITH TERRY —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD); State, Dept of (DOS); SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1908 (110th), H.R. 5418 (110th), H.R. 1432 (110th), H.R. 780 (110th), S. 1145 (110th), H.R. 5993 (110th), H.R. 6022 (110th), H.R. 1902 (110th), H.R. 5629 (110th), H.R. 1038 (110th), S. 316 (110th), H.R. 5120 (110th)

Health Issues HCR

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
VERA GRILL —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
RON ROBERTS —
MYRON KEITH TERRY —
ANNE WILSON —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Veterans Affairs, Dept of (VA); Treasury, Dept of; Patent & Trademark Office (PTO)

Bills named: H.R. 6331 (110th), H.R. 1424 (110th), H.R. 3697 (110th), H.R. 5605 (110th), H.R. 5501 (110th), H.R. 6378 (110th), S. 2408 (110th), S. 1693 (110th), H.R. 6376 (110th), H.R. 4296 (110th), H.R. 962 (110th), H.R. 806 (110th), S. 1432 (110th), S. 358 (110th), H.R. 2406 (110th), H.R. 4911 (110th), S. 349 (110th), H.R. 6898 (110th), S. 2313 (110th), H.R. 3800 (110th), S. 438 (110th), S. 2029 (110th), S. 316 (110th), H.R. 6357 (110th), S. 1082 (110th), S. 3396 (110th), S. 877 (110th)

Medicare/Medicaid MMM

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act HR 2567, Medicare Home Infusion Therapy Coverage Act of 2007

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
VERA GRILL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
MYRON KEITH TERRY —
ANNE WILSON —

Contacted: Executive Office of the President (EOP); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Commerce, Dept of (DOC); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 1014 (110th), H.R. 3162 (110th), H.R. 6331 (110th), H.R. 3963 (110th), H.R. 976 (110th), H.R. 118 (110th), H.R. 2567 (110th), H.R. 1424 (110th), H.R. 4 (110th)

Budget/Appropriations BUD

H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; Patent & Trademark Office (PTO); Defense, Dept of (DOD); Executive Office of the President (EOP); Food & Drug Administration (FDA); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3161 (110th), S.Con.Res. 21 (110th), S.Con.Res. 18 (110th), S.Con.Res. 70 (110th), H.R. 3610 (110th), S. 1710 (110th), H.Con.Res. 312 (110th), H.R. 3043 (110th), S. 3633 (110th)

Environment/Superfund ENV

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation HR 6451 Drug Free Water Act of 2008, Environmental Conservation HR 6820 Water Study Act of 2008, Environmental Conservation

LobbyistCovered position, as disclosed
LOUIS A LAMARCA —
ROBERT NORTON —
ANTHONY PRINCIPI —

Contacted: SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Defense, Dept of (DOD); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA)

Bills named: H.R. 6820 (110th), H.R. 2850 (110th), H.R. 6451 (110th)

Torts TOR

S. 2041 False Claims Act Correction Act of 2007 HR. 4854 False Claims Act Correction Act of 2007

LobbyistCovered position, as disclosed
ROBERT NORTON —
ANTHONY PRINCIPI —

Contacted: Executive Office of the President (EOP); Treasury, Dept of; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Commerce, Dept of (DOC); State, Dept of (DOS)

Bills named: S. 2041 (110th), H.R. 4854 (110th)

Agriculture AGR

HR. 6432 - Animal Drug User Fee Amendments of 2008. HR. 3161 - Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08

LobbyistCovered position, as disclosed
CHRISTOPHER CAREY —
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Treasury, Dept of; State, Dept of (DOS); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Veterans Affairs, Dept of (VA); SENATE

Bills named: H.R. 3161 (110th), H.R. 6432 (110th)

Consumer Issues/Safety/Products CSP

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
DOLLY JUDGE —
LOUIS A LAMARCA —
ANTHONY PRINCIPI —
MYRON KEITH TERRY —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Defense, Dept of (DOD); Patent & Trademark Office (PTO); Veterans Affairs, Dept of (VA); SENATE

Bills named: H.R. 380 (110th), H.R. 2900 (110th), S. 242 (110th), H.R. 780 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.